Exome Sequencing and Congenital Heart Disease in Sub-Saharan Africa.
Exome Sequencing and Congenital Heart Disease in Sub-Saharan Africa.
复制标题
撒哈拉以南非洲的外显子组测序和先天性心脏病。
DOI:
10.1161/circgen.120.003108
复制
发表时间:
2021-03
期刊:
影响因子:
--
通讯作者:
Kruszka P
中科院分区:
文献类型:
--
作者:
Ekure EN;Adeyemo A;Liu H;Sokunbi O;Kalu N;Martinez AF;Owosela B;Tekendo-Ngongang C;Addissie YA;Olusegun-Joseph A;Ikebudu D;Berger SI;Muenke M;Han Z;Kruszka P
Congenital heart disease (CHD) is the most common birth defect and affects roughly 1% of the global population. There have been a number of large CHD sequencing projects in developing countries, but none in sub-Saharan Africa. In this exome sequencing study, we recruited families from Lagos, Nigeria affected by structural heart disease. Ninety-eight participants with CHD and an average age of 3.6 years were recruited from Lagos, Nigeria. Exome sequencing was performed on probands, and parents when available. For genes of high interest, we conducted functional studies in Drosophila using a cardiac-specific RNA interference (RNAi)-based gene silencing system. The three most common CHDs were tetralogy of Fallot (20%), isolated ventricular septal defect (14%), and transposition of the great arteries (8%). Ten percent of the cohort had pathogenic or likely pathogenic variants in genes known to cause CHD. In 64 complete trios, we found 34 de novo variants that were not present in the African population in the gnomAD (v3) database. Nineteen loss of function variants were identified using the genome wide distribution of selection effects for heterozygous protein truncating variants (shet). Nine genes caused a significant mortality when silenced in the Drosophila heart, including 4 novel disease genes not previously associated with CHD (UBB, EIF4G3, SREBF1, and METTL23). This study identifies novel candidate genes and variants for CHD and facilitates comparisons with previous CHD sequencing studies in predominantly European cohorts. The study represents an important first step in genomic studies of CHD in under-studied populations.